Novo Nordisk A/S (NVO)

59.90 +1.09 (+1.85%) USD  |  NYSE  |  Jan 12, 16:00
60.64 +0.74 (+1.24%) After-Hours: 18:51
More

Novo Nordisk Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Ascendis Pharma A/S --
Evaxion AS --
Regeneron Pharmaceuticals, Inc. Upgrade
Omeros Corp. --
Viking Therapeutics, Inc. --